Selected article for: "international license and viral pneumonia"
Author: Lichao Fan; Chang Liu; Na Li; Huan Liu; Ye Gu; Yongyu Liu; Yu Chen
Title: Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study
  • Document date: 2020_3_30
    • ID: hc0za6fh_23
    Snippet: In terms of antimicrobial use, the WHO recommends empirical antimicrobial therapy based on the clinical diagnosis. 3 China's COVID-19 Diagnosis and Treatment Plan 2 also emphasizes the avoidance of blind or inappropriate use of antibiotics. Kim et al. 12 found that 38% of their patients . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The WHO .....
    Document: In terms of antimicrobial use, the WHO recommends empirical antimicrobial therapy based on the clinical diagnosis. 3 China's COVID-19 Diagnosis and Treatment Plan 2 also emphasizes the avoidance of blind or inappropriate use of antibiotics. Kim et al. 12 found that 38% of their patients . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The WHO does not recommend the systematic use of glucocorticoids for viral pneumonia or concurrent ARDS. 3 China's COVID-19 Diagnosis and Treatment Plan recommends hormones as adjuvant therapy. 2 In the present study, 48 (87·28% ) of the patients did not receive glucocorticoids, while 7 (12·72%) did receive such agents during the rapid progression of their disease to inhibit inflammation and improve oxygenation at a dose of 1-2 mg/kg/day. Treatment was gradually reduced over 5-7 days until discontinuation, and showed no adverse reactions. As such, glucocorticoids appear to be unnecessary for patients with mild manifestations of COVID-19, while their use in treating patients with severe disease is controversial.

    Search related documents:
    Co phrase search for related documents
    • adjuvant therapy and clinical diagnosis: 1, 2
    • adverse reaction and antimicrobial therapy: 1
    • adverse reaction and clinical diagnosis: 1, 2, 3
    • antimicrobial therapy and clinical diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antimicrobial therapy and empirical antimicrobial therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • cc NC International license and clinical diagnosis: 1, 2, 3, 4, 5, 6, 7
    • cc NC International license and disease rapid progression: 1
    • clinical diagnosis and empirical antimicrobial therapy: 1